Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $43,363,000 | $44,706,000 | $40,709,000 | $38,606,000 |
| % Growth | -3% | 9.8% | 5.4% | – |
| Cost of Goods Sold | $24,234,000 | $25,252,000 | $22,301,000 | $20,300,000 |
| Gross Profit | $19,129,000 | $19,454,000 | $18,408,000 | $18,306,000 |
| % Margin | 44.1% | 43.5% | 45.2% | 47.4% |
| R&D Expenses | $0 | $162,000 | $214,000 | $433,000 |
| G&A Expenses | $3,953,000 | $3,633,000 | $1,677,000 | $1,481,000 |
| SG&A Expenses | $10,992,000 | $10,100,000 | $4,599,000 | $4,396,000 |
| Sales & Mktg Exp. | $7,039,000 | $6,467,000 | $2,922,000 | $2,915,000 |
| Other Operating Expenses | $6,700,000 | $2,194,000 | $0 | $0 |
| Operating Expenses | $17,692,000 | $12,456,000 | $9,465,000 | $9,468,000 |
| Operating Income | $1,437,000 | $6,998,000 | $7,822,000 | $8,671,000 |
| % Margin | 3.3% | 15.7% | 19.2% | 22.5% |
| Other Income/Exp. Net | -$1,560,000 | -$1,284,000 | -$1,267,000 | -$537,000 |
| Pre-Tax Income | -$123,000 | $5,714,000 | $6,555,000 | $8,134,000 |
| Tax Expense | $960,000 | $1,310,000 | $1,327,000 | $1,646,000 |
| Net Income | -$1,083,000 | $4,404,000 | $5,228,000 | $6,488,000 |
| % Margin | -2.5% | 9.9% | 12.8% | 16.8% |
| EPS | -2.44 | 9.91 | 11.77 | 14.32 |
| % Growth | -124.6% | -15.8% | -17.8% | – |
| EPS Diluted | -2.44 | 9.91 | 11.77 | 14.32 |
| Weighted Avg Shares Out | 444,000 | 444,220 | 444,200 | 453,000 |
| Weighted Avg Shares Out Dil | 444,000 | 444,200 | 444,200 | 453,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $358,000 | $999,000 | $509,000 | $92,000 |
| Interest Expense | $1,649,000 | $2,227,000 | $1,324,000 | $765,000 |
| Depreciation & Amortization | $635,000 | $1,973,000 | $1,788,000 | $1,713,000 |
| EBITDA | $2,161,000 | $9,914,000 | $9,667,000 | $10,612,000 |
| % Margin | 5% | 22.2% | 23.7% | 27.5% |